Genitourinary Cancers | Topics

 
Oncology Peer Review On-The-Go: Value of Geriatric Assessment in Patients With Genitourinary Carcinomas
November 22, 2021

Lead author, Quirin Zangl, MD, spoke with CancerNetwork about research published in the journal ONCOLOGY focusing on the importance comprehensive geriatric assessment tools for patients with genitourinary carcinomas.

Value of Geriatric Assessment in Patients With Genitourinary Carcinoma
October 19, 2021

This work from Quirin Zangl, MD, and colleagues to evaluate comprehensive geriatric assessment tools to better guide patients with urogenital carcinomas perioperatively and, consequently, to intensify or reduce hospital resource use.

FDA Converts Indication for Pembrolizumab as Frontline Therapy for Bladder Cancer to Full Approval
August 31, 2021

The FDA has granted a full approval to pembrolizumab for the treatment of platinum-ineligible patients with urothelial cancer.

Advanced Penile Cancer Presenting With Renal Failure
July 13, 2021

“MK,” a man aged 67 years, presented with fatigue and nausea to his primary care physician. CT staging scans confirmed the primary tumor and a suspicious left 1.2-cm inguinal lymph node but no distant metastases. MRI of the pelvis revealed complete replacement of the penis with tumor as well as invasion into the scrotum and bilateral groin soft tissue; additionally, early pubic bone invasion was present, with left groin lymphadenopathy. Biopsy verified squamous cell carcinoma of the penis, and discussion with the multidisciplinary team uroradiologist confirmed bony invasion.

Robert A. Figlin, MD, on Understanding the Cancer Journey in GU Malignancies
July 12, 2021

Robert A. Figlin, MD, details how his institution, Cedars-Sinai Cancer, is aiming to fully understand the cancer journey for those with genitourinary malignancies.

FDA Approves Enfortumab Vedotin For Locally Advanced/Metastatic Urothelial Carcinoma
July 09, 2021

Enfortumab vedotin-ejfv has been approved by the FDA for locally advanced or metastatic urothelial cancer.

Neal D. Shore, MD, on the Importance of Multidisciplinary Care in Advanced Prostate Cancer
June 21, 2021

Neal D. Shore, MD, FACS, discusses the importance of multidisciplinary care for patients with advanced prostate cancer.

Petros Grivas, MD, PhD, on Updates in Genitourinary Oncology From ASCO 2021
June 20, 2021

Petros Grivas, MD, PhD, regarding updates in genitourinary oncology that were read out at the meeting.

Petros Grivas, MD, PhD, on the Impact of First-Line Maintenance Avelumab in Advanced Urothelial Carcinoma
June 18, 2021

Petros Grivas, MD, PhD, discusses the impact of avelumab on patients with advanced urothelial carcinoma in the first-line maintenance setting.

Trimodal Pembrolizumab-Based Combo Shows Safety and Efficacy Treating MIBC
June 08, 2021

Pembrolizumab plus gemcitabine and concurrent hypofractionated radiotherapy to treat patients with MIBC demonstrated safety and efficacy.